The Largest Ever Myeloma Screening PROMISE Study with Irene Ghobrial, MD, Dana Farber Cancer Institute and the SU2C Dream Team

The new GSK Antibody Drug Conjugate in Multiple Myeloma with Dr. Maria Chaudhry, OSU James Cancer Center

Mid-Year Myeloma Update with Paul Richardson, MD of the Dana Farber Cancer Institute

Tips for Joining Popular Multiple Myeloma Clinical Trials with Brian McMahon of SparkCures

Overcoming Proteasome Inhibitor Resistance, Muhamed Baljevic, MD, University of Nebraska

Introducing HealthTree for Multiple Myeloma Patients with Rafael Fonseca, MD, Mayo Clinic Scottsdale

New York Round Table - May 5, 2018

First Risk-Adapted Therapy Trial for Newly Diagnosed Patients (the MASTER trial) with Luciano Costa, MD, PhD, UAB

Charlotte Round Table - April 14, 2018